FibroGen's market cap is currently $58.95M. The company's EPS TTM is $-1.229; its P/E ratio is ―; FibroGen is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 147.75M	$ 140.73M	$ 235.31M	$ 176.32M	$ 256.58M
Gross Profit	$ 128.90M	$ 120.45M	$ 222.44M	$ 167.45M	$ 255.43M
Operating Income	$ -281.81M	$ -301.02M	$ -288.53M	$ -191.88M	$ -89.31M
EBITDA	$ -261.40M	$ -282.82M	$ -274.80M	$ -164.28M	$ -52.31M
Net Income	$ -284.23M	$ -295.23M	$ -291.03M	$ -189.29M	$ -76.97M
Balance Sheet
Cash & Short-Term Investments	$ 235.59M	$ 422.01M	$ 405.19M	$ 686.54M	$ 533.76M
Total Assets	$ 423.53M	$ 610.09M	$ 773.82M	$ 826.84M	$ 857.40M
Total Debt	$ 170.46M	$ 89.89M	$ 99.73M	$ 37.72M	$ 51.10M
Net Debt	$ 56.77M	$ -65.81M	$ -71.49M	$ -640.67M	$ -75.16M
Total Liabilities	$ 585.73M	$ 611.57M	$ 544.71M	$ 385.39M	$ 321.99M
Stockholders' Equity	$ -204.17M	$ -21.45M	$ 209.15M	$ 422.18M	$ 516.13M
Cash Flow
Free Cash Flow	$ -317.54M	$ -184.67M	$ -112.42M	$ 77.61M	$ -84.47M
Operating Cash Flow	$ -315.02M	$ -145.93M	$ -82.23M	$ 81.60M	$ -78.70M
Investing Cash Flow	$ 153.66M	$ 89.12M	$ -426.97M	$ 452.49M	$ 120.02M
Financing Cash Flow	$ 122.75M	$ 46.78M	$ -563.00K	$ 13.34M	$ -4.30M

Currency in USD

FibroGen Earnings and Revenue History

Income Statement >

FibroGen Debt to Assets

Balance Sheet >

FibroGen Cash Flow

Cash Flow >

FibroGen Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing